🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer, Lenvatinib
Sun Yat-sen University
Not applicable
274
Changsha
2022-07-01
Active, closed
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
NCT05918133TNBC
Biotheus Inc.
Phase 1/2
42
Chongqing, Harbin, Nanjing, Nanchang, Jinan, Shanghai, Yibin, Tianjin
2022-07-01
Recruiting
Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
NCT05597709Type 2 Diabetes Mellitus in Remission, Metabolic Associated Fatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd
Observational
2,900
Nanjing
2022-07-01
Active, closed
Acupoint Application With Yanqing Zhitong Ointment for Chronic Non-specific Low Back Pain
NCT06102291Non-specific Low Back Pain
ZhanYJ
Not applicable
150
Shanghai
2022-07-01
Active, closed
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
NCT05170438Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan
Phase 2
51
2022-07-01
Recruiting
Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
NCT05735145Uterine Cervical Neoplasms, Chemoradiotherapy, Adjuvant Chemotherapy
Fourth Affiliated Hospital of Guangxi Medical University
Phase 3
108
Liuzhou
2022-07-01
Recruiting
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039Breast Neoplasms
Fudan University
Observational
20,000
Shanghai
2022-07-01
Active, closed
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05365178HR-positive, HER2-negative Breast Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
432
Bengbu, Wuhu, Beijing, Chongqing, Fuzhou, Lanzhou, Wuwei, Guangzhou
2022-07-01
Recruiting
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
NCT05722405Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
100
Hangzhou
2022-07-01
By invitation
Clinical Study on the Integration of Traditional Chinese Medicine Virtual Hanging Therapy With Mesenchymal Stem Cells for the Treatment of Crohn's Disease-Associated Anal Fistula.
NCT07113795Crohn's Disease With Perianal Fistulas
The Anorectal Center of Nanjing Hospital of Traditional Chinese Medicine
Phase EARLY_PHASE1
90
Nanjing
2022-07-01
Recruiting
Prediction of Vascular Events After Major Non-Cardiac Surgery : an Observational Prospective Cohort Study
NCT05812248Noncardiac Surgery
Nanfang Hospital, Southern Medical University
Observational
20,000
Guangzhou
2022-07-01
Active, closed
Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy
NCT06954259NSCLC (Advanced Non-small Cell Lung Cancer)
Qiang Xu
Observational
272
Nanchang
2022-07-01
Recruiting
Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
NCT05789030Autoimmune Diseases
Peking Union Medical College Hospital
Not applicable
60
Beijing
2022-07-01
Recruiting
Non-invasive Filling Pressure(NIFP) Device Based on Low Frequency Heart Sound in Assessment of Congestion in Heart Failure Patients
NCT06593223Heart Failure
The University of Hong Kong-Shenzhen Hospital
Observational
400
Shenzhen
2022-07-01
Recruiting
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
NCT06827899Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University
Phase 2
66
Xiamen
2022-07-01
Not yet open
Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
NCT05420480Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Not applicable
323
Shanghai
2022-07-01
Recruiting
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
NCT05430971Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Immune Oncology Research Institute
Observational
200
2022-07-01
Not yet open
Observation of the Natural Course of Age-related Macular Degeneration
NCT05418231Dry Age-related Macular Degeneration, Macular Degeneration, Dry
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
500
Shanghai
2022-07
Not yet open
Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China
NCT05451082Hepatitis D
Lai Wei
Observational
1,000
Beijing
2022-07
Recruiting
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors
NCT05688605Advanced Solid Tumors
Lepu Biopharma Co., Ltd.
Phase 1/2
18
Guangzhou, Changsha
2022-06-30
By invitation
The Gut Microbiota and Metabolites in HFpEF
NCT06645535HFpEF - Heart Failure With Preserved Ejection Fraction
The First Affiliated Hospital with Nanjing Medical University
Observational
300
Naning
2022-06-30
Recruiting
Reverse Triple Negative Immune Resistant Breast Cancer
NCT05076682Triple-negative Breast Cancer
Fudan University
Phase 2
80
Shanghai
2022-06-30
Active, closed
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
NCT05456425Pterygium
Cloudbreak Therapeutics, LLC
Phase 3
660
Beijing, Chengdu, Haikou, Hengyang, Kunming, Nanchang, Qingdao, Wenzhou
2022-06-30
Active, closed
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
NCT05364073Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, HER2 Exon 20 Mutations
ArriVent BioPharma, Inc.
Phase 1
160
Hefei, Beijing, Chaoyang, Chongqing, Harbin, Zhengzhou, Wuhan, Xuzhou
2022-06-30
Active, closed
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)
NCT05382364Metastatic HER2+ Advanced Breast Cancer, Breast Neoplasms, Gastric or Gastroesophageal Junction Adenocarcinoma (GEC), Colorectal Cancer
Pfizer
Phase 1
25
Harbin, Changsha, Changchun, Shanghai, Tianjin
2022-06-29
Active, closed
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
NCT05461339Neovascular Age-related Macular Degeneration
BioDlink Biopharm Co., Ltd.
Phase 3
488
Hefei, Beijing, Jilin City, Chongqing, Fuzhou, Guangzhou, Shantou, Shenzhen
2022-06-28
Recruiting
Ofatumumab in AQP4-IgG Seropositive NMOSD
NCT05504694Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital
Phase 1/2
5
Xi'an
2022-06-28
Active, closed
A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC
NCT05319431Unresectable, Non-metastatic Hepatocellular Carcinoma
Akeso
Phase 2
60
Beijing, Guangzhou, Zhengzhou, Changsha, Jinan
2022-06-28
Recruiting
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
NCT05378087Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Not applicable
1,956
Chongqing
2022-06-27
Recruiting
Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)
NCT05511792Aortic Stenosis With Bicuspid Valve
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
206
Fuzhou, Xiamen, Lanzhou, Guangzhou, Yulin, Zhengzhou, Changsha, Nanchang
2022-06-27
Active, closed
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
NCT05382442Metastatic Colorectal Cancer
Akeso
Phase 2
254
Guanzhou
2022-06-27
Recruiting
AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
NCT05404906Acute Myeloid Leukemia (AML) in Remission
The First Affiliated Hospital of Soochow University
Phase 2/3
124
Suzhou
2022-06-25
Active, closed
Observational Study in Multiple System Atrophy
NCT05453058Multiple System Atrophy
H. Lundbeck A/S
Observational
90
Beijing, Changsha, Chengdu, Shanghai, Suzhou
2022-06-25
Recruiting
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
NCT05523245Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
1,700
Guangzhou, Zhuhai
2022-06-24
Active, closed
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
NCT05405166Plasma Cell Myeloma Recurrent
Sanofi
Phase 3
531
Beijing, Changsha, Guangzhou, Hangzhou, Nanchang, Nanning, Qingdao, Shenyang
2022-06-23
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
Celgene
Phase 3
939
Changsha, Nanchang, Xi'an, Shanghai, Taiyuan, Wenzhou, Beijing, Changchun
2022-06-23
Active, closed
Clinical Trial to Evaluate MDW for Early Detection of Sepsis
NCT06267742Sepsis
Beckman Coulter, Inc.
Observational
2,200
Beijing, Chengdu, Hangzhou
2022-06-23
Recruiting
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
NCT05436093Solid Tumor
Peking University Cancer Hospital & Institute
Not applicable
50
Beijing
2022-06-23
Active, closed
Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
NCT05464433Extranodal Natural Killer T Cell Lymphoma
Sun Yat-sen University
Phase 1/2
46
Beijing, Dalian, Guangzhou, Nanchang
2022-06-23
Active, closed
Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC
NCT05459415Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
54
Wuhan
2022-06-22
Active, closed
NAC for Treatment-Resistant OCD and Other Related Disorders
NCT06956157Obsessive Compulsive Disorder (OCD)
Guangdong Provincial People's Hospital
Phase 4
90
GuangDong
2022-06-22
Recruiting
Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN
NCT05416905Craniofacial Dystonia, Deep Brain Stimulation
Beijing Tiantan Hospital
Not applicable
110
Beijing
2022-06-22
Active, closed
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
NCT05235516Locally Advanced Cervical Carcinoma
Akeso
Phase 3
636
Beijing, Guiyang, Wuhan, Changsha, Shanghai, Chengdu, Hangzhou
2022-06-21
Recruiting
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT05430399Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer
Sun Yat-sen University
Phase 3
349
Guangzhou, Hunan
2022-06-21
Recruiting
A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
NCT05603078Breast Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
102
Beijing
2022-06-21
Recruiting
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
NCT05773937Advanced Malignant Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1
40
Beijing
2022-06-21
Recruiting
MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC
NCT05286957NSCLC
The First Affiliated Hospital of Zhengzhou University
Phase 2
60
Zhengzhou
2022-06-20
Active, closed
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
NCT05444491Colorectal Cancer
Singlera Genomics Inc.
Observational
800
Beijing, Chengdu, Guangzhou, Haerbin, Shanghai, Shenzhen, Taiyuan
2022-06-20
Active, closed
MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)
NCT04841811Lung Cancer
Guangdong Association of Clinical Trials
Phase 3
192
Guangzhou
2022-06-20
Active, closed
Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
NCT05363800Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
74
Zhengzhou, Shengyang, Hangzhou
2022-06-17
Active, closed
Efficacy of Triple-Combination Therapy in Severe PAH-CHD
NCT06196801Congenital Heart Disease, Pulmonary Arterial Hypertension
Guangdong Provincial People's Hospital
Observational
80
Guangzhou
2022-06-17
Active, closed
SQ-Kyrin-T First-in-man Feasibility Study
NCT06605313Tricuspid Regurgitation
Shanghai Shenqi Medical Technology Co., Ltd
Not applicable
12
Kunming
2022-06-16
Not yet open
The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer
NCT05411809Stereotactic Body Radiation Therapy
Peking University Third Hospital
Not applicable
180
Beijing
2022-06-15
Recruiting
Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
NCT05378334Non-small Cell Lung Cancer
Guangzhou University of Traditional Chinese Medicine
Not applicable
82
Guangzhou
2022-06-15
Recruiting
The Effectiveness of Written Exposure Therapy for PTSD
NCT05421494PTSD, Subclinical PTSD
Peking University
Not applicable
135
Beijing
2022-06-15
Recruiting
The Jinling Cohort
NCT06011694Cancer, Multi Cancer Early Screening, Liquid Biopsy
Nanjing Shihejiyin Technology, Inc.
Observational
15,000
Nanjing
2022-06-15
Active, closed
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
NCT05132075Non-Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 3
95
Fuzhou, Guangzhou, Harbin, Changsha, Shengyang, Jinan, Hangzhou, Beijing
2022-06-15
Recruiting
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
NCT05405595Advanced/Metastatic Solid Tumors
Adagene Inc
Phase 1/2
186
Fuzhou, Guangzhou, Hong Kong
2022-06-15
Active, closed
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
NCT05047250Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 3
60
Beijing, Changsha, Chongqing, Fuzhou, Hangzhou, Hefei, Linyi, Nanjing
2022-06-14
Active, closed
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
NCT05283720Non-Hodgkin Lymphoma
Genmab
Phase 2
264
Beijing, Shanghai
2022-06-14
Recruiting
Multi-parametric Magnetic Resonance Imaging for the Precise Diagnosis and Quantitative Study of Liver Steatosis, Inflammation, and Fibrosis in Chronic Liver Disease.
NCT06463366Liver Stiffness
Shengjing Hospital
Observational
100
Shenyang
2022-06-14
Active, closed
A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)
NCT05426369Chemotherapy-induced Thrombocytopenia (CIT)
Sichuan Clover Biopharmaceuticals, Inc.
Phase 1
36
Chengdu
2022-06-14
Recruiting
Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia
NCT05445011Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
12
Wuhan
2022-06-14
Recruiting
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
NCT05302284Urothelial Carcinoma, HER2-expressing
RemeGen Co., Ltd.
Phase 3
452
Beijing
2022-06-14
Active, closed
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
NCT05348733Chronic Kidney Disease, Type 2 Diabetes Mellitus
Bayer
Observational
4,613
Multiple Locations
2022-06-13
Recruiting
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
NCT05316493Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity
Xiaojun Chen
Phase 2/3
172
Shanghai
2022-06-13
By invitation
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
NCT05352919Systemic Lupus Erythematosus (SLE)
Biogen
Phase 3
864
Beijing, Dongguan, Guangzhou, Shenzhen, Zhongshan, Haikou, Shijiazhuang, Changsha
2022-06-10
Recruiting
A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery
NCT05242419Injection, Non-cardiac Surgery, Delirium in Old Age, Post Operative Delirium
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2022-06-10
Active, closed
SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
NCT05347134Triple Negative Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
254
Beijing, Nanjing
2022-06-10
Active, closed
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
NCT05211232Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
450
Zhanjiang, Wuzhou, Guiyang, Changsha
2022-06-10
Recruiting
Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy
NCT05341141Breast Cancer
Peking University
Not applicable
102
Beijing
2022-06-10
Active, closed
Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer
NCT05407155Non-small Cell Lung Cancer Metastatic
Fudan University
Not applicable
56
Shanghai
2022-06-09
Recruiting
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
NCT06998108HR+/HER2- Locally Advanced, Metastatic Breast Cancer
BeBetter Med Inc
Phase 3
330
Beijing
2022-06-09
Active, closed
A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)
NCT05347225Hematological Malignancies
Merck Sharp & Dohme LLC
Phase 1
12
Guangzhou, Zhengzhou, Changsha, Tianjin
2022-06-09
Recruiting
Surgery vs Biologics for Treating Stricturing CD--a RCT
NCT05421455Crohn Disease
Zhu Weiming
Not applicable
138
Nanjing
2022-06-09
Active, closed
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.
NCT05797714HBV Infection, Chronic Hepatitis b
Ruijin Hospital
Not applicable
200
Changsha, Beijing, Dongyang, Fuyang, Hangzhou, Lishui, Nanchang, Nanjin
2022-06-08
Active, closed
Effect of FMD on Colorectal Cancer Patients
NCT05384444Fasting Mimicking Diet, Colorectal Cancer
Fudan University
Not applicable
602
Shanghai
2022-06-08
Recruiting
Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
NCT05382728NSCLC, EGFR Activating Mutation
TYK Medicines, Inc
Phase 3
680
Changsha, Shanghai
2022-06-08
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
NCT05382559Solid Tumor
Astellas Pharma Inc
Phase 1
681
Beijing, Xuhui District, Shanghai
2022-06-08
Recruiting
Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.
NCT05397769Locally Advanced Nasopharyngeal Carcinoma, Envafolimab, Induction Chemotherapy, PD-L1
Sun Yat-sen University
Phase 2
36
Guangzhou
2022-06-08
Recruiting
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
NCT05205109Locally Advanced or Metastatic Solid Tumors
Antengene Therapeutics Limited
Phase 1
98
Chongqing, Guangzhou
2022-06-07
Active, closed
KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT05294172Nasopharyngeal Carcinoma, Recurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
295
Beijing
2022-06-07
Recruiting
Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
NCT05288179Pneumoconiosis
Beijing Continent Pharmaceutical Co, Ltd.
Phase 3
272
Beijing
2022-06-07
Recruiting
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
NCT05365581Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 1
398
Guangzhou, Zhengzhou, Wuhan, Shanghai, Hangzhou
2022-06-07
Recruiting
Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
NCT05407792Bronchiectasis
Qianfoshan Hospital
Not applicable
134
Jinan
2022-06-06
Recruiting
The Dampness Syndrome of Chinese Medicine Cohort Study
NCT05315895Chronic Disease, Cancer, Dementia Alzheimers, Metabolic Disease
Guangzhou University of Traditional Chinese Medicine
Observational
100,000
Guangzhou
2022-06-06
Recruiting
NOACs Use in AF or VTE (SUNSHINE Registry)
NCT05378308Atrial Fibrillation, Venous Thromboembolism, Oral Anticoagulant
Henan Provincial People's Hospital
Observational
5,000
Zhengzhou
2022-06-06
Recruiting
COVID-19 Immunity and Changes Over Time
NCT05271669COVID-19
Chinese University of Hong Kong
Observational
1,350
Hong Kong
2022-06-06
By invitation
Preservation of Venous Valvular Function After PMT for Acute DVT
NCT05588284Acute Deep Venous Thrombosis of Femoral Vein (Disorder)
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
100
Chuzhou, Shanghai, Taizhou
2022-06-06
Active, closed
Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement
NCT05390216Pacemaker Complication, Infections
Shanghai Zhongshan Hospital
Not applicable
1,016
Shanghai
2022-06-05
Recruiting
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)
NCT07083336Type 2 Diabetes Mellitus, Metabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology
Not applicable
120
Yichang, Changsha
2022-06-05
Recruiting
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
NCT05262010HPV InfectioN, HPV-Related Carcinoma
National Vaccine and Serum Institute, China
Phase 3
13,500
Hechi, Hezhou, Lianyuan, Wuxi, Yongji, Yuncheng, Mianyang, Neijiang
2022-06-04
Recruiting
Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors
NCT05367778Advanced Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2
176
Wuhan
2022-06-03
Recruiting
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer
NCT05618821Gastric Cancer
Fujian Medical University
Phase 2
68
Fuzhou
2022-06-03
Active, closed
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
NCT05195632Non-Small Cell Lung Cancer
Pierre Fabre Medicament
Phase 2
63
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou
2022-06-02
Recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
NCT05252078Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Esophageal Diseases, Gastrointestinal Neoplasms
Jiangxi Provincial Cancer Hospital
Phase 2
30
Nanchang
2022-06-02
Active, closed
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003Clinical High Risk, Psychosis, Remission, Conversion
Brigham and Women's Hospital
Observational
2,617
Shanghai
2022-06-02
Recruiting
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
NCT05326399Liver Transplantation, Renal Insufficiency, Chronic
RenJi Hospital
Observational
369
Shanghai
2022-06-01
Not yet open
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
NCT05294653Atherosclerotic Cardiovascular Disease, Childhood Diabetes Mellitus, Juvenile Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
300
Shanghai
2022-06-01
Recruiting
Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)
NCT05227534Cancer, Early Detection of Cancer, Circulating Cell-free DNA
Guangzhou Burning Rock Dx Co., Ltd.
Not applicable
12,500
Chengdu
2022-06-01
Rows per page Showing 16501–16600 of 19052
Previous 164 165 166 167 168 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=166

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.